Global incidence of pertussis after the COVID-19 pandemic
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F25%3A00015120" target="_blank" >RIV/75010330:_____/25:00015120 - isvavai.cz</a>
Výsledek na webu
<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842103" target="_blank" >https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842103</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1001/jamanetworkopen.2025.45963" target="_blank" >10.1001/jamanetworkopen.2025.45963</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Global incidence of pertussis after the COVID-19 pandemic
Popis výsledku v původním jazyce
Importance Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants. Observations In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries. Conclusions and Relevance The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.
Název v anglickém jazyce
Global incidence of pertussis after the COVID-19 pandemic
Popis výsledku anglicky
Importance Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants. Observations In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries. Conclusions and Relevance The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30302 - Epidemiology
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
JAMA Network Open
ISSN
2574-3805
e-ISSN
2574-3805
Svazek periodika
8
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
12
Strana od-do
e2545963
Kód UT WoS článku
001631834200006
EID výsledku v databázi Scopus
2-s2.0-105023453553